Lenvatinib Combined With TACE to Prevent the Recurrence in High-risk Patients With Hepatocellular Carcinoma
Clinical trial NCT03838796 · UNKNOWN
Trial details
- NCT number
- NCT03838796
- Sponsor
- Fudan University
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-03
- Primary completion
- 2022-06-30
- Enrollment
- 297
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.